Background: Hemoglobin A1c (HbA1c) is a good marker for monitoring glycemic control. The Samsung LABGEO PT10 HbA1c test (Samsung Electronics, Korea) was developed as a point-of-care testing approach. This study evaluated the levels of HbA1c in three different types of blood specimens using two different methods. Methods: We used correlation analyses to compare the results obtained using Samsung LABGEO PT10 and Bio-Rad Variant II Turbo (Bio-Rad Laboratories, USA) to determine the levels of HbA1c in three different types of blood samples: capillary blood, EDTA whole blood, and lithium (Li)-heparin whole blood. Results: The correlation coefficient for the level of HbA1c in capillary blood based on LABGEO PT10 vs. that in EDTA whole blood based on the Variant II Turbo was r=0.9619; that in capillary blood based on LABGEO PT10 vs. that in Li-heparin whole blood based on the Variant II Turbo was r=0.9619; that in capillary blood vs. that in EDTA whole blood based on the LABGEO PT10 was r=0.9697; that in capillary blood vs. that in Li-heparin whole blood based on the LABGEO PT10 was r=0.9724; and that in EDTA whole blood vs. that in Li-heparin whole blood based on the LABGEO PT10 was r=0.9730. Conclusions: The LABGEO PT10 was suitable for analyzing HbA1c. The results for the measurement of HbA1c levels in capillary blood were comparable to that in the whole blood samples. Additionally, LABGEO PT10 can be used for patients who are unable to take venipuncture.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disease that is caused by defects in insulin secretion or peripheral resistance of the tissues 세 종류의 혈액 검체에서 Samsung LABGEO PT10과 Variant II Turbo의 HbA1c 측정능 비교 평가 (NGSP), which specifies a value of 6.5% as positive diagnosis of DM, while values ranging from 5.7-6.4% are considered as high risk for diabetes. HbA1c measurement via point-of-care testing (POCT) can shorten the report time without pre-treatment of the sample, such as transportation to a central laboratory and centrifugation after collection. POCT typically requires minimal personnel training and can be easily performed by doctors as well as nurses [5, 6] . Based on the prompt return of the results, POCT is very convenient for patients, as it enables immediate treatment planning without additional clinic visits.
The LABGEO PT10 analyzer (Samsung Electronics, Suwon, Korea) is a POCT device used for clinical chemistry test items with good reported analytical performance [7] . LABGEO PT10 Hemoglobin A1c cartridges (Samsung Electronics) have recently been developed and can be used in diabetic care. In this study, we evaluated the difference in LABGEO PT10 HbA1c values in capillary blood, EDTA whole blood, and lithium (Li)-heparin whole blood. The HbA1c reference values were determined using a DCCT aligned cationic exchange high performance liquid chromatography (HPLC) analyzer.
MATERIALS AND METHODS

Study Design
This study was approved by the institutional review board of Samsung Medical Center. HbA1c values were measured in 76 individuals aged 23-82 yr (median 58 yr). Of the 76 participants, 41 (54%) were male and 35 (46%) were female. Several blood samples were collected from the volunteers simultaneously and were used for HbA1c testing. Capillary blood was collected in heparinized capillary tubes (Kimble Chase Life Science, Rockwood, TN, USA) from a finger prick and was tested using the LABGEO PT10. 
Venous blood was collected in a BD
Statistical Analysis
For sample comparisons, Passing-Bablok regression and BlandAltman plots were prepared and Cohen's kappa (κ) value was determined using MedCalc ver. 14.10.2 (MedCalc Software, Mar-iakerke, Belgium).
RESULTS
The central laboratory method results for the EDTA whole blood samples indicated that the range for the Variant II Turbo was 4.8-10.2% (median 6.3%) and the Li-heparin whole blood sample range for the Variant II Turbo was 4.8-9.9% (median 6.1%).
All samples, including capillary blood, were appropriately distributed. The correlation coefficient (r) for capillary blood using the LABGEO PT10 vs. EDTA whole blood analysis using the Variant II Turbo was r = 0.9619, and that of capillary blood using the LAB-GEO PT10 vs. Li-heparin whole blood analysis using the Variant II Turbo was r = 0.9619 ( Fig. 1 ).
Using the LABGEO PT10, the correlation coefficient was r = 0.9697 for capillary blood vs. EDTA whole blood, r = 0.9724 for capillary blood vs. Li-heparin whole blood, and r = 0.9730 for EDTA whole blood vs. Li-heparin whole blood (Fig. 2 ).
The average HbA1c bias for each type of sample that was compared (with 95% confidence intervals in parentheses) as observed HbA1c values obtained using the IFCC method are 1.5-2% lower than the NGSP results. When the IFCC unit is reported, an equation can be used to convert the value to a relative NGSP value:
152. In addition, a recent consensus recommends that the results be reported in both units [12] .
In this study, we determined the HbA1c levels in three sample types and using two instruments. The results indicated that the correlation between LABGEO PT10 among capillary blood, EDTA whole blood, and Li-heparin whole blood was good (capillary blood vs. EDTA whole blood, r = 0.9697; capillary blood vs.
Li-heparin whole blood, r = 0.9724; EDTA whole blood vs. Li-heparin whole blood, r = 0.9730). Excellent concordance was observed between capillary blood and EDTA (κ = 0.816), capillary blood and Li-heparin (κ = 0.831), and EDTA blood and Li-heparin blood (κ = 0.875). These findings suggest that the LABGEO PT10
can be used in various clinical environments to accurately determine the HbA1c levels.
Although good correlation was observed in the LABGEO PT10 testing of capillary blood, EDTA whole blood, and Li-heparin whole blood, there were some limitations to our study. In this study, the interference from hemoglobin variants was not evalu- were between 3.8% and 4.2% [7] . In HbA1c measurement, it is recommended that intralaboratory coefficient of variation <2% and an interlaboratory coefficient of variation <3.5% [15] . However, meeting this stringent criterion is very difficult, and it seems inappropriate to impose this goal on POCT devices [16] .
However, previous studies did not compare sample types such as EDTA whole blood and capillary blood. In this study, we evaluated HbA1c values in three types of samples (capillary blood, EDTA whole blood, and Li-heparin whole blood). Various HbA1c levels were included in the comparison analysis and good correlation and concordance were observed among the three types of blood samples using the two different analytical instruments.
In conclusion, the LABGEO PT10 can rapidly measure HbA1c 
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